Navigation Links
US Patent Allowed for NOD Tech
Date:11/24/2009

SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. announced the US Patent & Trademark Office (PTO) has allowed the patent application for its nano-particle oral delivery or NOD technology.

NOD technology is a highly efficient approach to incorporate peptides or proteins into bio-adhesive nano-particles to enable oral delivery of drugs otherwise administered as injections. NOD technology is a platform technology that can be applied to many macromolecular drugs such as insulin, interferon, growth hormone, exenatide, heparin and more.

Currently, an oral insulin formulation, the first candidate developed with NOD technology, is entering phase I clinical studies in China.

"Patent allowance for NOD technology is a major step forward for NOD", quoted from William Lee, CEO. "With this patent, and in combination with others, NOD is building a solid foundation for its intellectual property and core competence."

    For more information, please contact:

     William Lee, Ph.D., CEO
     Phone: +86-21-6194-0758
     Email: info@nodpharm.com


    Notes for Editors

About NOD Pharmaceuticals

NOD Pharmaceuticals, Inc. is a development stage biotech company and emerging leader in innovative delivery for biopharmaceuticals. NOD uses patented platform technology, nano-particle oral delivery or NOD technology, to develop oral formulations for biopharmaceuticals, including insulin, exenatide, interferon, human growth hormone and more.

More information can be found at http://www.nodpharm.com .

SOURCE NOD Pharmaceuticals, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information
2. BioLife Solutions Granted Japanese Biopreservation Patent
3. Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
4. AvidBiotics Corp. Granted Key U.S. and European Patents on Unique Protein Modification Platform
5. Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
6. Celsis IVT Granted U.S. Patent for LiverPool(TM) Hepatocytes
7. Athera Receives Allowance of Two Key Patents
8. Jeremy M. Stipkala to Lead Symposium Entitled Patent Law Developments at SERMACS 2009
9. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
10. ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System
11. Martek Announces Settlement of Patent Dispute with Capsugel France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... Corista, a ... and artificial intelligence Tuesday, July 25, during the Association of Pathology Chairs’ Jubilee ... Medicine. , Baras, Associate Director of Pathology Informatics, will present “The Digital ...
(Date:7/18/2017)... ... ... Sourcing custom glass or quartz parts can be a daunting task. Finding ... your job can take many hours of emails, phone calls and on-line research. Wilmad-LabGlass’ ... the company’s capabilities and core custom categories, and enables you to start the quoting ...
(Date:7/18/2017)... Fairfield, NJ (PRWEB) , ... July 18, 2017 ... ... in corporate finance technology, DataForm Software ( https://dataformsoftware.com ) announces the migration of ... – to Microsoft Azure. Planet is a team-centric, enterprise work management system that ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental ... wide range of overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) ... NDD research and testing. , However, designing a custom panel for disease ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
Breaking Biology News(10 mins):